Refine by
Applications
- Duodenal Mucosal Resurfacing System (DMR) for Type 2 Diabetes
- Duodenal Mucosal Resurfacing System (DMR) for Clinical Research Studies
- Duodenal Mucosal Resurfacing System (DMR) for T2Di Study
- Duodenal Mucosal Resurfacing System (DMR) for Healthcare Professionals
- RNA Technology for Research Fellowship
- RNA Technology for Medical Areas of Focus Research
- RNA Technology for Product Pipeline Research
- RNA Technology for Clinical trials
Type 1 Diabetes Equipment & Supplies
134 equipment items found
Manufactured by:Caelus Health based inAmsterdam, NETHERLANDS
CH-0301: the third drug intervention is based on FMT in Type 1 Diabetes; first aim is to confirm the clinical data, which were generated in the FMT discovery ...
by:Diabetomics, Inc. based inHillsboro, OREGON (USA)
The first and only point-of-care tests for early detection of type-1 diabetes and LADA (Latent Autoimmune Diabetes in ...
Manufactured by:Medipan GmbH based inBlankenfelde-Mahlow, GERMANY
Radio ligand assay for the quantitative determination of autoantibodies to Insulin (IAA) in human ...
by:Modular Medical, Inc. based inSan Diego, CALIFORNIA (USA)
The MODD1 was designed to be affordable enough for free sampling and trial, and simple enough for self-guided user training and use. This is the product the industry has needed to take the step into ...
Manufactured by:Sana Biotechnology based inSeattle, WASHINGTON (USA)
Diabetes: Type 1 ...
Manufactured by:Inversago Pharma based inMontreal, QUEBEC (CANADA)
Inversago Pharma Inc. is focused on the development of peripherally-acting CB1 receptor (CB1) inverse agonists for the treatment of diabetic nephropathy, NASH, type 1 diabetes and Prader-Willi Syndrome. While previous generation of centrally-acting CB1 inhibitors presented safety concerns, the therapeutic relevance of peripheral ...
Manufactured by:Ikarovec based inNorwich, UNITED KINGDOM
Diabetic macular edema (DME) is the most common cause of sight loss in diabetics. The longer you have diabetes, the greater your chance of developing sight loss. About 90% of people with type 1 diabetes will have some degree of retinopathy after 10 years. For people with type 2 ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Dalazatide can be used in the study of autoimmune diseases such as multiple sclerosis (MS), lupus erythematosus, psoriasis, rheumatoid arthritis, type 1 diabetes and inflammatory bowel ...
by:Kadimastem Ltd. based inNes-Ziona, ISRAEL
We Have Reached Successful Pre-clinical results of our cell Therapy Treatment for Insulin-Dependent Diabetes. Diabetes mellitus is a chronic disorder characterized by high blood glucose levels and glucose intolerance, due to insulin deficiency, impaired effectiveness of insulin action, or both. Diabetes is classified on the basis of cause and ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Albiglutide is a glucagon-like peptide-1 agonist (GLP-1) biologic drug indicated in the treatment of type 2 diabetes. It is a dipeptidyl peptidase-4-resistant glucagon-like peptide-1 dimer fused to human albumin.https://www.creative-peptides.com/product/albiglutide-item-10-101-158-33644.html ...
Manufactured by:Creative Peptides based inNew York, NEW YORK (USA)
Taspoglutide is a pharmaceutical drug, a glucagon-like peptide-1 agonist (GLP-1 agonist), under investigation for treatment of type 2 diabetes being codeveloped by Ipsen and Roche.https://www.creative-peptides.com/product/taspoglutide-item-10-101-176-33662.html ...
Manufactured by:Takeda Pharmaceutical Company Limited based inChuo-ku, JAPAN
Alogliptin benzoate (brand name: Nesina) is a treatment for hyperglycemia (high blood glucose) in Type 2 ...
Manufactured by:MuseChem based inPaoli, PENNSYLVANIA (USA)
Semaglutide is a recombinant DNA-produced polypeptide analog of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the therapy of type 2 diabetes, either alone or in combination with other antidiabetic agents. This product is used for pharmaceutical research and development, and other ...
Manufactured by:Caelus Health based inAmsterdam, NETHERLANDS
E. hallii: as basis of a drug to treat Type 2 diabetes has already been tested in 3 clinical trials in MetS/prediabetes and the next trial in Type 2 diabetes is scheduled to start in the first half of ...
Manufactured by:SEQENS Group based inÉcully, FRANCE
Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Metformin hydrochloride (1,1-Dimethylbiguanide hydrochloride) inhibits themitochondrial respiratory chainin the liver, leading to activation ofAMPK, enhancing insulin sensitivity for type 2 diabetes research. Metformin hydrochloride ...
Manufactured by:Caelus Health based inAmsterdam, NETHERLANDS
Intestinimonas: as basis of a drug to treat Type 2 Diabetes has been tested in animal trials; a first clinical Proof of Concept study will start in ...
Manufactured by:Jiangsu Xietong Pharmaceutical Bio-engineering Co., Ltd. based inNanjing City, CHINA
Rodent Diet with 45% Calories from Fat (ref. D12451) and its adjusted formula are widely used in the establishment of obesity and type 2 diabetes and other disease models in rats, and its advantage lies in its stable modeling cycle and high modeling ...
Manufactured by:Jiangsu Xietong Pharmaceutical Bio-engineering Co., Ltd. based inNanjing City, CHINA
Rodent Diet with 60% Calories from Fat (ref. D12492) and its adjusted formula are widely used in the establishment of obesity and type 2 diabetes and other disease models in rats, and its advantage lies in its stable modeling cycle and high modeling ...
Manufactured by:Oramed Pharmaceuticals, Inc. based inNew York, NEW YORK (USA)
Glucagon-like peptide-1 (GLP-1) is an incretin hormone that stimulates the secretion of insulin from the pancreas. Exenatide, a GLP-1 analog, is currently marketed in injectable form, and is indicated for treatment of type 2 diabetes. Exenatide induces insulin release at increased glucose levels and causes a ...